Application 202671
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IBANDRONATE SODIUM | IBANDRONATE SODIUM | INJECTABLE;INTRAVENOUS | EQ 3MG BASE/3ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 67457-524 | ibandronate sodium | ibandronate sodium | Mylan Institutional LLC | ANDA | Current |